companydata.dkUnibio USA ApS: Financial statements 2022
CVR: 38179845
Unibio USA ApS (CVR 38179845) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -18,000 and a net result of DKK -34,000 compared with DKK -12,000 the year before. Equity amounted to DKK 88,000. The solvency ratio was 87.1%.
- Gross Profit
- -18,000 kr.
- Profit/Loss
- -34,000 kr.
- Equity
- 88,000 kr.
- Total Assets
- 101,000 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -18 t. | -34 t. | 88 t. | 0 |
| 2021 | - | -15 t. | -12 t. | 72 t. | 0 |
| 2020 | - | -14 t. | -11 t. | 8 t. | 0 |
| 2019 | - | -15 t. | -12 t. | 19 t. | 0 |
| 2018 | - | -15 t. | -12 t. | 31 t. | 0 |
Keep an eye on Unibio USA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Unibio USA ApS has published its annual report for 2021. Gross profit came to DKK -15,000, and the net result was DKK -12,000.
About Unibio USA ApS
Unibio USA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Søren Olrik Eklund and David Richard Henstrom. The company is owned by UNIBIO A/S. In 2025, the company reported a net result of DKK -20,000 compared with DKK -26,000 the year before. Equity amounted to DKK 25,000.